圣诺生物
(688117)
| 流通市值：27.65亿 | | | 总市值：27.65亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 337,836,114.63 | 198,937,738.87 | 104,057,251.91 | 435,021,032.33 |
| 营业收入 | 337,836,114.63 | 198,937,738.87 | 104,057,251.91 | 435,021,032.33 |
| 二、营业总成本 | 272,013,119.71 | 176,467,279.26 | 86,932,598.39 | 357,476,689.72 |
| 营业成本 | 138,539,550.35 | 80,403,223.79 | 38,373,417.24 | 157,649,159.41 |
| 税金及附加 | 3,166,909.96 | 2,578,861.95 | 1,324,269.24 | 4,034,079.76 |
| 销售费用 | 49,354,000.33 | 35,677,629.03 | 23,176,474.16 | 107,972,070.62 |
| 管理费用 | 45,280,270.26 | 30,481,157.65 | 12,618,455.3 | 53,862,951.84 |
| 研发费用 | 28,578,274.28 | 23,832,884.61 | 9,416,771.26 | 29,047,663.23 |
| 财务费用 | 7,094,114.53 | 3,493,522.23 | 2,023,211.19 | 4,910,764.86 |
| 其中:利息费用 | 8,955,940.93 | 5,267,331.5 | 2,936,363.16 | 9,264,942.18 |
| 其中:利息收入 | 1,708,002.98 | 1,231,947.24 | 838,481.68 | 3,919,910.51 |
| 加:投资收益 | 624,137.28 | 697,983.61 | 298,891.63 | -1,420,958.21 |
| 资产处置收益 | -3,717.56 | 35 | 35 | -1,061.71 |
| 资产减值损失(新) | -4,721,467.96 | -4,751,478.35 | -874,479.67 | -4,930,227.92 |
| 信用减值损失(新) | -943,025.01 | 1,954,459.15 | 1,431,408.93 | -3,047,193.55 |
| 其他收益 | 3,603,264.22 | 3,435,789.64 | 1,607,099.75 | 12,956,194.45 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 64,382,185.89 | 23,807,248.66 | 19,587,609.16 | 81,101,095.67 |
| 加:营业外收入 | 207,582.21 | 26,106.26 | 21,333.96 | 333,478.55 |
| 减:营业外支出 | 668,773.22 | 533,423.43 | 307,634.57 | 1,313,056.31 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 63,920,994.88 | 23,299,931.49 | 19,301,308.55 | 80,121,517.91 |
| 减:所得税费用 | 7,104,987.68 | 1,581,627.39 | 2,851,172.56 | 9,797,076.88 |
| 六、净利润 | 56,816,007.2 | 21,718,304.1 | 16,450,135.99 | 70,324,441.03 |
| 持续经营净利润 | 56,816,007.2 | 21,718,304.1 | 16,450,135.99 | 70,324,441.03 |
| 归属于母公司股东的净利润 | 56,946,626.77 | 21,787,611.98 | 16,472,225.12 | 70,337,139.39 |
| 少数股东损益 | -130,619.57 | -69,307.88 | -22,089.13 | -12,698.36 |
| (一)基本每股收益 | 0.51 | 0.19 | 0.15 | 0.63 |
| (二)稀释每股收益 | 0.51 | 0.19 | 0.15 | 0.62 |
| 九、综合收益总额 | 56,816,007.2 | 21,718,304.1 | 16,450,135.99 | 70,324,441.03 |
| 归属于母公司股东的综合收益总额 | 56,946,626.77 | 21,787,611.98 | 16,472,225.12 | 70,337,139.39 |
| 归属于少数股东的综合收益总额 | -130,619.57 | -69,307.88 | -22,089.13 | -12,698.36 |
| 公告日期 | 2024-10-29 | 2024-07-31 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |